Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 111-58-0
2. N-(2-hydroxyethyl)oleamide
3. Oleoyl Ethanolamide
4. (z)-n-(2-hydroxyethyl)octadec-9-enamide
5. Oleoyl Monoethanolamide
6. Oleic Monoethanolamide
7. N-(9z-octadecenoyl)-ethanolamine
8. N-(cis-9-octadecenoyl) Ethanolamine
9. 1hi5j9n8e6
10. 9-octadecenamide, N-(2-hydroxyethyl)-
11. Dtxsid1044516
12. 9-octadecenamide, N-(2-hydroxyethyl)-, (9z)-
13. Chebi:71466
14. Refchem:856533
15. Dtxcid9024516
16. 203-884-8
17. Oleoylethanolamine
18. N-oleoylethanolamine
19. Oleylethanolamide
20. Oleamide Mea
21. N-oleoyl Ethanolamine
22. N-oleoylethanolamide
23. N-oleoyl Ethanolamide
24. Mfcd00045972
25. N-(2-hydroxyethyl)-9-octadecenamide
26. (9z)-n-(2-hydroxyethyl)octadec-9-enamide
27. Oleic Acid Ethanolamide
28. N-(hydroxyethyl)oleamide
29. N-(hydroxyethyl) Oleamide
30. Oea
31. Chembl280065
32. N-?oleoylethanolamide
33. Sr-01000076041
34. Einecs 203-884-8
35. Unii-1hi5j9n8e6
36. Monoethanolamine Oleic Acid Amide
37. 9-octadecenamide, N-(2-hydroxyethyl)-, (z)-
38. 5ym
39. Olemsartan Medoximil
40. C18:1 Anandamide
41. Oleoyl 1-ethanolamide
42. Tocris-1484
43. N-oleoyl-2-aminoethanol
44. Oleoylethanolamide (oea)
45. Spectrum5_002037
46. Lopac-o-0383
47. Oleic Acid Monoethanolamide
48. Lopac0_000942
49. Mls002153155
50. Schembl177713
51. Gtpl2661
52. Orb1309303
53. Bdbm29080
54. N-(9z-octadecenoyl) Ethanolamine
55. Glxc-22224
56. Hms2233e21
57. Hms3262n06
58. Hms3412d21
59. Hms3649j05
60. Hms3676d21
61. Oleylethanolamide [who-dd]
62. Nae 18:1
63. Tox21_500942
64. Lmfa08040015
65. Msk159624
66. N-oleoylethanolamine, ~98% (tlc)
67. Nae(18:1)
68. Akos015839895
69. N-(2-hydroxyethyl)-9z-octadecenamide
70. Ccg-205023
71. Lp00942
72. Msk159624-100m
73. Sdccgsbi-0050916.p002
74. Msk159624-1000m
75. Ncgc00015761-01
76. Ncgc00015761-02
77. Ncgc00015761-03
78. Ncgc00015761-04
79. Ncgc00015761-05
80. Ncgc00015761-06
81. Ncgc00015761-07
82. Ncgc00015761-12
83. Ncgc00025182-01
84. Ncgc00025182-02
85. Ncgc00025182-04
86. Ncgc00025182-05
87. Ncgc00025182-06
88. Ncgc00261627-01
89. As-15152
90. Bp-43134
91. Fo180525
92. Smr001230650
93. Sy102076
94. Hy-107542
95. Cs-0028847
96. Eu-0100942
97. Ns00013916
98. O0345
99. C20792
100. D82195
101. O 0383
102. 111o580
103. 9-octadecenamide, N-(2-hydroxyethyl)-, Z
104. A802386
105. Q7086404
106. Sr-01000076041-1
107. Sr-01000076041-3
108. Sr-01000076041-8
109. Brd-k66956375-001-11-3
110. C18:1 Anandamide, 9z-octadecenoylethanolamide, Powder
111. N-oleoylethanolamine Solution In Methanol, 1000ug/ml
112. N-oleoylethanolamine Solution In Methanol, 100ug/ml
113. (z)-n-(2-hydroxyethyl)octadec-9-enamide;oleoylethanolamide
114. N-oleoylethanolamide; Oleamide Mea; Oleic Acid Monoethanolamide
115. N-oleoyl Ethanolamine, Oleoyl Monoethanolamide, Oleoylethanolamide
116. N-oleoylethanolamine; (9z)-n-(2-hydroxyethyl)-9-octadecenamide; Oleic Acid Ethanolamide
| Molecular Weight | 325.5 g/mol |
|---|---|
| Molecular Formula | C20H39NO2 |
| XLogP3 | 6.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 17 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 49.3 |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 277 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Oleoylethanolamide (OEA) is a major N-acylethanolamine and an endogenous ethanolamide fatty acid. Although it is an endocannabinoids-like compound, it does not bind to cannabinoid receptors. Instead, this lipid sensor is an agonist at peroxisome proliferator-activated receptor- (PPAR-) agonist while also being an inhibitor of ceramidase and thereby the sphingolipid signaling pathway.
ABOUT THIS PAGE
27
PharmaCompass offers a list of Oleoylethanolamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Oleoylethanolamide manufacturer or Oleoylethanolamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oleoylethanolamide manufacturer or Oleoylethanolamide supplier.
A Oleoylethanolamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oleoylethanolamide, including repackagers and relabelers. The FDA regulates Oleoylethanolamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oleoylethanolamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oleoylethanolamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Oleoylethanolamide supplier is an individual or a company that provides Oleoylethanolamide active pharmaceutical ingredient (API) or Oleoylethanolamide finished formulations upon request. The Oleoylethanolamide suppliers may include Oleoylethanolamide API manufacturers, exporters, distributors and traders.
click here to find a list of Oleoylethanolamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Oleoylethanolamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oleoylethanolamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Oleoylethanolamide GMP manufacturer or Oleoylethanolamide GMP API supplier for your needs.
A Oleoylethanolamide CoA (Certificate of Analysis) is a formal document that attests to Oleoylethanolamide's compliance with Oleoylethanolamide specifications and serves as a tool for batch-level quality control.
Oleoylethanolamide CoA mostly includes findings from lab analyses of a specific batch. For each Oleoylethanolamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oleoylethanolamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Oleoylethanolamide EP), Oleoylethanolamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oleoylethanolamide USP).
